ADAGE CAPITAL PARTNERS GP LLC Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for ADAGE CAPITAL PARTNERS GP LLC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of ADAGE CAPITAL PARTNERS GP LLC. ADAGE CAPITAL PARTNERS GP LLC is 10% Owner in AMAG PHARMACEUTICALS INC. ($AVM) and in CPAC INC ($CPAK) and 10% Owner in CPAC INC ($CPAK) and in HUBBELL INC ($HUBA, HUBB) and 10% Owner in HUBBELL INC ($HUBA, HUBB) and 10% Owner in PACIFIC SUNWEAR OF CALIFORNIA INC ($PSUN) and 10% Owner in MED-DESIGN CORP ($MEDC) and 10% Owner in MANTECH INTERNATIONAL CORP ($MANT) and in SELECT COMFORT CORP ($SCSS) and 10% Owner in SELECT COMFORT CORP ($SCSS) and 10% Owner in Advaxis, Inc. ($ADXS) and 10% Owner in iGo, Inc. ($MOBE) and 10% Owner in Cardiome Pharma Corp ($CRME) and 10% Owner in FIVE PRIME THERAPEUTICS INC ($FPRX) and 10% Owner in Vitae Pharmaceuticals, Inc ($VTAE) and in BOULDER BRANDS, INC. ($BSBR) and 10% Owner in BOULDER BRANDS, INC. ($BSBR) and 10% Owner in ORBCOMM Inc. ($ORBC) and 10% Owner in MULESOFT, INC ($MULE) and 10% Owner in HeartWare International, Inc. ($HTWR) and 10% Owner in PUMA BIOTECHNOLOGY, INC. ($PBYI) and 10% Owner in Calithera Biosciences, Inc. ($CALA) and 10% Owner in Solaris Oilfield Infrastructure, Inc. ($SOI) and 10% Owner in Royalty Pharma plc ($RPRX).
Latest Insider Trading Transactions of ADAGE CAPITAL PARTNERS GP LLC
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, ADXS, AVM, BSBR, CALA, CRME, CPAK, FPRX, HTWR, HUBA, HUBB, MOBE, MANT, MEDC, MULE, ORBC, PSUN, PBYI, RPRX, SNBR, SOI, VTAE
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dec 18 2020 | RPRX | Royalty Pharma plc | ADAGE CAPITAL PARTNERS GP, L.L ... | 10% Owner | Sell | S | 44.02 | 101,050 | 4,448,221 | 38,714,280 | 38.8 M to 38.7 M (-0.26 %) |
| Dec 18 2020 | RPRX | Royalty Pharma plc | ADAGE CAPITAL PARTNERS GP, L.L ... | 10% Owner | Sell | S | 43.92 | 7,200,000 | 316,224,000 | 38,815,330 | 46 M to 38.8 M (-15.65 %) |
| Aug 13 2020 | ORBC | ORBCOMM Inc. | ADAGE CAPITAL PARTNERS GP, L.L ... | 10% Owner | Sell | S | 4.31 | 100,000 | 431,000 | 7,697,220 | 7.8 M to 7.7 M (-1.28 %) |
| Jun 22 2020 | RPRX | Royalty Pharma plc | ADAGE CAPITAL PARTNERS GP, L.L ... | 10% Owner | Option Exercise | C | 0.00 | 4,637,046 | 0 | 335,513 | |
| Jun 22 2020 | RPRX | Royalty Pharma plc | ADAGE CAPITAL PARTNERS GP, L.L ... | 10% Owner | Buy | P | 28.00 | 3,000,000 | 84,000,000 | 46,015,330 | 43 M to 46 M (+6.97 %) |
| Jun 22 2020 | RPRX | Royalty Pharma plc | ADAGE CAPITAL PARTNERS GP, L.L ... | 10% Owner | Buy | C | 0.00 | 43,015,330 | 0 | 43,015,330 | 0 to 43 M |
| Nov 22 2019 | ORBC | ORBCOMM Inc. | ADAGE CAPITAL PARTNERS GP, L.L ... | 10% Owner | Sell | S | 3.99 | 21,100 | 84,210 | 7,828,550 | 7.8 M to 7.8 M (-0.27 %) |
| Nov 22 2019 | ORBC | ORBCOMM Inc. | ADAGE CAPITAL PARTNERS GP, L.L ... | 10% Owner | Sell | S | 4.04 | 112,901 | 456,064 | 7,849,650 | 8 M to 7.8 M (-1.42 %) |
| Oct 12 2017 | ADXS | Advaxis, Inc. | ADAGE CAPITAL PARTNERS GP, L.L ... | 10% Owner | Sell | S | 4.30 | 600,000 | 2,580,000 | 4,100,043 | 4.7 M to 4.1 M (-12.77 %) |
| Sep 28 2017 | CALA | Calithera Bioscien ... | ADAGE CAPITAL PARTNERS GP, L.L ... | 10% Owner | Sell | S | 15.50 | 38,000 | 589,000 | 3,546,873 | 3.6 M to 3.5 M (-1.06 %) |
| Sep 28 2017 | CALA | Calithera Bioscien ... | ADAGE CAPITAL PARTNERS GP, L.L ... | 10% Owner | Sell | S | 15.59 | 186,000 | 2,899,740 | 3,584,873 | 3.8 M to 3.6 M (-4.93 %) |
| Sep 28 2017 | CALA | Calithera Bioscien ... | ADAGE CAPITAL PARTNERS GP, L.L ... | 10% Owner | Sell | S | 15.68 | 352,000 | 5,519,360 | 3,770,873 | 4.1 M to 3.8 M (-8.54 %) |
| Sep 26 2017 | ADXS | Advaxis, Inc. | ADAGE CAPITAL PARTNERS GP, L.L ... | 10% Owner | Sell | S | 4.00 | 300,000 | 1,200,000 | 4,700,043 | 5 M to 4.7 M (-6.00 %) |
| Sep 26 2017 | ADXS | Advaxis, Inc. | ADAGE CAPITAL PARTNERS GP, L.L ... | 10% Owner | Sell | S | 4.38 | 405,323 | 1,775,315 | 5,000,043 | 5.4 M to 5 M (-7.50 %) |
| Sep 26 2017 | ADXS | Advaxis, Inc. | ADAGE CAPITAL PARTNERS GP, L.L ... | 10% Owner | Sell | S | 4.68 | 534,000 | 2,499,120 | 5,405,366 | 5.9 M to 5.4 M (-8.99 %) |
| Jun 12 2017 | PBYI | PUMA BIOTECHNOLOGY ... | ADAGE CAPITAL PARTNERS GP, L.L ... | 10% Owner | Sell | S | 80.08 | 11,697 | 936,734 | 3,696,580 | 3.7 M to 3.7 M (-0.32 %) |
| Jun 12 2017 | PBYI | PUMA BIOTECHNOLOGY ... | ADAGE CAPITAL PARTNERS GP, L.L ... | 10% Owner | Sell | S | 79.19 | 77,247 | 6,117,136 | 3,708,277 | 3.8 M to 3.7 M (-2.04 %) |
| Jun 12 2017 | PBYI | PUMA BIOTECHNOLOGY ... | ADAGE CAPITAL PARTNERS GP, L.L ... | 10% Owner | Sell | S | 81.29 | 24,110 | 1,959,878 | 3,785,524 | 3.8 M to 3.8 M (-0.63 %) |
| Jun 12 2017 | PBYI | PUMA BIOTECHNOLOGY ... | ADAGE CAPITAL PARTNERS GP, L.L ... | 10% Owner | Sell | S | 80.41 | 34,206 | 2,750,552 | 3,809,634 | 3.8 M to 3.8 M (-0.89 %) |
| Jun 12 2017 | PBYI | PUMA BIOTECHNOLOGY ... | ADAGE CAPITAL PARTNERS GP, L.L ... | 10% Owner | Sell | S | 81.49 | 10,462 | 852,588 | 3,843,840 | 3.9 M to 3.8 M (-0.27 %) |
| Jun 12 2017 | PBYI | PUMA BIOTECHNOLOGY ... | ADAGE CAPITAL PARTNERS GP, L.L ... | 10% Owner | Sell | S | 80.88 | 89,538 | 7,242,021 | 3,854,302 | 3.9 M to 3.9 M (-2.27 %) |
| Jun 05 2017 | PBYI | PUMA BIOTECHNOLOGY ... | ADAGE CAPITAL PARTNERS GP, L.L ... | 10% Owner | Sell | S | 99.08 | 11,668 | 1,156,063 | 3,943,840 | 4 M to 3.9 M (-0.29 %) |
| Jun 05 2017 | PBYI | PUMA BIOTECHNOLOGY ... | ADAGE CAPITAL PARTNERS GP, L.L ... | 10% Owner | Sell | S | 96.61 | 52,016 | 5,025,495 | 3,955,508 | 4 M to 4 M (-1.30 %) |
| Jun 05 2017 | PBYI | PUMA BIOTECHNOLOGY ... | ADAGE CAPITAL PARTNERS GP, L.L ... | 10% Owner | Sell | S | 92.00 | 3,083 | 283,636 | 4,007,524 | 4 M to 4 M (-0.08 %) |
| Jun 05 2017 | PBYI | PUMA BIOTECHNOLOGY ... | ADAGE CAPITAL PARTNERS GP, L.L ... | 10% Owner | Sell | S | 91.31 | 23,272 | 2,125,055 | 4,010,607 | 4 M to 4 M (-0.58 %) |
| Jun 05 2017 | PBYI | PUMA BIOTECHNOLOGY ... | ADAGE CAPITAL PARTNERS GP, L.L ... | 10% Owner | Sell | S | 90.21 | 152,762 | 13,781,149 | 4,033,879 | 4.2 M to 4 M (-3.65 %) |
| Jun 05 2017 | PBYI | PUMA BIOTECHNOLOGY ... | ADAGE CAPITAL PARTNERS GP, L.L ... | 10% Owner | Sell | S | 88.12 | 63,227 | 5,571,785 | 4,186,641 | 4.2 M to 4.2 M (-1.49 %) |
| Jun 05 2017 | PBYI | PUMA BIOTECHNOLOGY ... | ADAGE CAPITAL PARTNERS GP, L.L ... | 10% Owner | Sell | S | 85.32 | 1,100 | 93,850 | 4,249,868 | 4.3 M to 4.2 M (-0.03 %) |
| Jun 05 2017 | PBYI | PUMA BIOTECHNOLOGY ... | ADAGE CAPITAL PARTNERS GP, L.L ... | 10% Owner | Sell | S | 83.06 | 30,475 | 2,531,287 | 4,250,968 | 4.3 M to 4.3 M (-0.71 %) |
| Jun 05 2017 | PBYI | PUMA BIOTECHNOLOGY ... | ADAGE CAPITAL PARTNERS GP, L.L ... | 10% Owner | Sell | S | 83.55 | 5,200 | 434,436 | 4,281,443 | 4.3 M to 4.3 M (-0.12 %) |
| Jun 05 2017 | PBYI | PUMA BIOTECHNOLOGY ... | ADAGE CAPITAL PARTNERS GP, L.L ... | 10% Owner | Sell | S | 82.41 | 164,325 | 13,542,220 | 4,286,643 | 4.5 M to 4.3 M (-3.69 %) |
| May 26 2017 | PBYI | PUMA BIOTECHNOLOGY ... | ADAGE CAPITAL PARTNERS GP, L.L ... | 10% Owner | Sell | S | 78.35 | 330 | 25,857 | 4,450,968 | 4.5 M to 4.5 M (-0.01 %) |
| May 26 2017 | PBYI | PUMA BIOTECHNOLOGY ... | ADAGE CAPITAL PARTNERS GP, L.L ... | 10% Owner | Sell | S | 77.66 | 111,823 | 8,684,610 | 4,451,298 | 4.6 M to 4.5 M (-2.45 %) |
| May 26 2017 | PBYI | PUMA BIOTECHNOLOGY ... | ADAGE CAPITAL PARTNERS GP, L.L ... | 10% Owner | Sell | S | 76.72 | 187,847 | 14,410,795 | 4,563,121 | 4.8 M to 4.6 M (-3.95 %) |
| May 26 2017 | PBYI | PUMA BIOTECHNOLOGY ... | ADAGE CAPITAL PARTNERS GP, L.L ... | 10% Owner | Sell | S | 79.70 | 75,036 | 5,980,564 | 4,750,968 | 4.8 M to 4.8 M (-1.55 %) |
| May 26 2017 | PBYI | PUMA BIOTECHNOLOGY ... | ADAGE CAPITAL PARTNERS GP, L.L ... | 10% Owner | Sell | S | 78.25 | 7,248 | 567,121 | 4,826,004 | 4.8 M to 4.8 M (-0.15 %) |
| May 26 2017 | PBYI | PUMA BIOTECHNOLOGY ... | ADAGE CAPITAL PARTNERS GP, L.L ... | 10% Owner | Sell | S | 77.61 | 232,190 | 18,021,404 | 4,833,252 | 5.1 M to 4.8 M (-4.58 %) |
| May 26 2017 | PBYI | PUMA BIOTECHNOLOGY ... | ADAGE CAPITAL PARTNERS GP, L.L ... | 10% Owner | Sell | S | 76.91 | 85,526 | 6,577,471 | 5,065,442 | 5.2 M to 5.1 M (-1.66 %) |
| May 26 2017 | PBYI | PUMA BIOTECHNOLOGY ... | ADAGE CAPITAL PARTNERS GP, L.L ... | 10% Owner | Sell | S | 75.00 | 116,133 | 8,709,975 | 5,150,968 | 5.3 M to 5.2 M (-2.20 %) |
| May 26 2017 | PBYI | PUMA BIOTECHNOLOGY ... | ADAGE CAPITAL PARTNERS GP, L.L ... | 10% Owner | Sell | S | 74.49 | 48,865 | 3,639,817 | 5,267,101 | 5.3 M to 5.3 M (-0.92 %) |
| May 26 2017 | PBYI | PUMA BIOTECHNOLOGY ... | ADAGE CAPITAL PARTNERS GP, L.L ... | 10% Owner | Sell | S | 73.29 | 175,687 | 12,875,837 | 5,315,966 | 5.5 M to 5.3 M (-3.20 %) |
| May 26 2017 | PBYI | PUMA BIOTECHNOLOGY ... | ADAGE CAPITAL PARTNERS GP, L.L ... | 10% Owner | Sell | S | 72.22 | 52,300 | 3,776,933 | 5,491,653 | 5.5 M to 5.5 M (-0.94 %) |
| May 26 2017 | PBYI | PUMA BIOTECHNOLOGY ... | ADAGE CAPITAL PARTNERS GP, L.L ... | 10% Owner | Sell | S | 70.31 | 53,600 | 3,768,493 | 5,543,953 | 5.6 M to 5.5 M (-0.96 %) |
| May 26 2017 | PBYI | PUMA BIOTECHNOLOGY ... | ADAGE CAPITAL PARTNERS GP, L.L ... | 10% Owner | Sell | S | 69.00 | 39,115 | 2,698,935 | 5,597,553 | 5.6 M to 5.6 M (-0.69 %) |
| May 26 2017 | PBYI | PUMA BIOTECHNOLOGY ... | ADAGE CAPITAL PARTNERS GP, L.L ... | 10% Owner | Sell | S | 68.13 | 50,000 | 3,406,455 | 5,636,668 | 5.7 M to 5.6 M (-0.88 %) |
| May 16 2017 | SOI | Solaris Oilfield I ... | ADAGE CAPITAL PARTNERS GP, L.L ... | 10% Owner | Buy | P | 11.48 | 14,600 | 167,593 | 1,275,000 | 1.3 M to 1.3 M (+1.16 %) |
| May 16 2017 | SOI | Solaris Oilfield I ... | ADAGE CAPITAL PARTNERS GP, L.L ... | 10% Owner | Buy | P | 11.49 | 10,400 | 119,546 | 1,260,400 | 1.3 M to 1.3 M (+0.83 %) |
| May 16 2017 | SOI | Solaris Oilfield I ... | ADAGE CAPITAL PARTNERS GP, L.L ... | 10% Owner | Buy | P | 11.50 | 50,000 | 574,770 | 1,250,000 | 1.2 M to 1.3 M (+4.17 %) |
| Mar 24 2017 | CALA | Calithera Bioscien ... | ADAGE CAPITAL PARTNERS GP, L.L ... | 10% Owner | Buy | P | 10.25 | 487,804 | 4,999,991 | 4,122,873 | 3.6 M to 4.1 M (+13.42 %) |
| Mar 21 2017 | MULE | MULESOFT, INC | ADAGE CAPITAL PARTNERS GP, L.L ... | 10% Owner | Sell | S | 25.06 | 25,000 | 626,500 | 675,000 | 700 K to 675 K (-3.57 %) |
| Nov 17 2016 | CALA | Calithera Bioscien ... | ADAGE CAPITAL PARTNERS GP, L.L ... | 10% Owner | Buy | P | 3.15 | 500,000 | 1,575,000 | 3,635,069 | 3.1 M to 3.6 M (+15.95 %) |
| Sep 16 2016 | VTAE | Vitae Pharmaceutic ... | ADAGE CAPITAL PARTNERS GP, L.L ... | 10% Owner | Sell | S | 20.85 | 1,025,000 | 21,371,250 | 2,375,000 | 3.4 M to 2.4 M (-30.15 %) |
| Apr 07 2016 | PSUN | PACIFIC SUNWEAR OF ... | ADAGE CAPITAL PARTNERS GP, L.L ... | 10% Owner | Sell | S | 0.11 | 2,404,880 | 264,537 | 5,127,926 | 7.5 M to 5.1 M (-31.93 %) |
| Apr 07 2016 | PSUN | PACIFIC SUNWEAR OF ... | ADAGE CAPITAL PARTNERS GP, L.L ... | 10% Owner | Sell | S | 0.13 | 10,000 | 1,300 | 7,532,806 | 7.5 M to 7.5 M (-0.13 %) |
| Apr 07 2016 | PSUN | PACIFIC SUNWEAR OF ... | ADAGE CAPITAL PARTNERS GP, L.L ... | 10% Owner | Sell | S | 0.12 | 500,000 | 60,000 | 7,542,806 | 8 M to 7.5 M (-6.22 %) |
| Apr 07 2016 | PSUN | PACIFIC SUNWEAR OF ... | ADAGE CAPITAL PARTNERS GP, L.L ... | 10% Owner | Sell | S | 0.09 | 1,907,247 | 171,652 | 8,042,806 | 10 M to 8 M (-19.17 %) |
| Oct 19 2015 | FPRX | FIVE PRIME THERAPE ... | ADAGE CAPITAL PARTNERS GP LLC | 10% Owner | Sell | S | 27.00 | 25,000 | 675,000 | 2,539,949 | 2.6 M to 2.5 M (-0.97 %) |
| Oct 19 2015 | FPRX | FIVE PRIME THERAPE ... | ADAGE CAPITAL PARTNERS GP LLC | 10% Owner | Sell | S | 28.85 | 25,000 | 721,250 | 2,564,949 | 2.6 M to 2.6 M (-0.97 %) |
| Oct 19 2015 | FPRX | FIVE PRIME THERAPE ... | ADAGE CAPITAL PARTNERS GP LLC | 10% Owner | Sell | S | 27.58 | 65,687 | 1,811,647 | 2,589,949 | 2.7 M to 2.6 M (-2.47 %) |
| Oct 19 2015 | FPRX | FIVE PRIME THERAPE ... | ADAGE CAPITAL PARTNERS GP LLC | 10% Owner | Sell | S | 28.02 | 9,313 | 260,950 | 2,655,636 | 2.7 M to 2.7 M (-0.35 %) |
| Sep 24 2015 | CALA | Calithera Bioscien ... | ADAGE CAPITAL PARTNERS GP LLC | 10% Owner | Buy | P | 6.07 | 40,168 | 243,768 | 3,135,069 | 3.1 M to 3.1 M (+1.30 %) |
| Sep 24 2015 | CALA | Calithera Bioscien ... | ADAGE CAPITAL PARTNERS GP LLC | 10% Owner | Buy | P | 6.00 | 41,800 | 250,938 | 3,094,901 | 3.1 M to 3.1 M (+1.37 %) |
| Sep 24 2015 | CALA | Calithera Bioscien ... | ADAGE CAPITAL PARTNERS GP LLC | 10% Owner | Buy | P | 6.00 | 25,000 | 149,943 | 3,053,101 | 3 M to 3.1 M (+0.83 %) |
| Sep 08 2015 | CALA | Calithera Bioscien ... | ADAGE CAPITAL PARTNERS GP LLC | 10% Owner | Buy | P | 5.95 | 2,300 | 13,685 | 3,028,101 | 3 M to 3 M (+0.08 %) |
| Sep 08 2015 | CALA | Calithera Bioscien ... | ADAGE CAPITAL PARTNERS GP LLC | 10% Owner | Buy | P | 5.93 | 88,000 | 521,840 | 3,025,801 | 2.9 M to 3 M (+3.00 %) |
| Aug 28 2015 | CALA | Calithera Bioscien ... | ADAGE CAPITAL PARTNERS GP LLC | 10% Owner | Buy | P | 5.58 | 22,000 | 122,760 | 2,937,801 | 2.9 M to 2.9 M (+0.75 %) |
| Aug 28 2015 | CALA | Calithera Bioscien ... | ADAGE CAPITAL PARTNERS GP LLC | 10% Owner | Buy | P | 5.55 | 20,700 | 114,885 | 2,915,801 | 2.9 M to 2.9 M (+0.72 %) |
| Aug 28 2015 | CALA | Calithera Bioscien ... | ADAGE CAPITAL PARTNERS GP LLC | 10% Owner | Buy | P | 5.35 | 32,400 | 173,340 | 2,895,101 | 2.9 M to 2.9 M (+1.13 %) |
| Aug 28 2015 | CALA | Calithera Bioscien ... | ADAGE CAPITAL PARTNERS GP LLC | 10% Owner | Buy | P | 5.17 | 29,089 | 150,390 | 2,862,701 | 2.8 M to 2.9 M (+1.03 %) |
| Aug 28 2015 | CALA | Calithera Bioscien ... | ADAGE CAPITAL PARTNERS GP LLC | 10% Owner | Buy | P | 5.58 | 19,578 | 109,245 | 2,833,612 | 2.8 M to 2.8 M (+0.70 %) |
| Aug 28 2015 | CALA | Calithera Bioscien ... | ADAGE CAPITAL PARTNERS GP LLC | 10% Owner | Buy | P | 5.43 | 6,253 | 33,954 | 2,814,034 | 2.8 M to 2.8 M (+0.22 %) |
| Aug 28 2015 | CALA | Calithera Bioscien ... | ADAGE CAPITAL PARTNERS GP LLC | 10% Owner | Buy | P | 5.41 | 9,848 | 53,278 | 2,807,781 | 2.8 M to 2.8 M (+0.35 %) |
| Aug 28 2015 | CALA | Calithera Bioscien ... | ADAGE CAPITAL PARTNERS GP LLC | 10% Owner | Buy | P | 4.65 | 32,058 | 149,070 | 2,797,933 | 2.8 M to 2.8 M (+1.16 %) |
| Aug 28 2015 | CALA | Calithera Bioscien ... | ADAGE CAPITAL PARTNERS GP LLC | 10% Owner | Buy | P | 4.70 | 200 | 940 | 2,765,875 | 2.8 M to 2.8 M (+0.01 %) |
| Aug 24 2015 | ADXS | Advaxis, Inc. | ADAGE CAPITAL PARTNERS GP LLC | 10% Owner | Buy | P | 14.47 | 12,100 | 175,087 | 5,939,366 | 5.9 M to 5.9 M (+0.20 %) |
| Aug 24 2015 | ADXS | Advaxis, Inc. | ADAGE CAPITAL PARTNERS GP LLC | 10% Owner | Buy | P | 13.73 | 9,500 | 130,435 | 5,927,266 | 5.9 M to 5.9 M (+0.16 %) |
| Aug 24 2015 | ADXS | Advaxis, Inc. | ADAGE CAPITAL PARTNERS GP LLC | 10% Owner | Buy | P | 14.06 | 3,400 | 47,804 | 5,917,766 | 5.9 M to 5.9 M (+0.06 %) |
| Aug 24 2015 | ADXS | Advaxis, Inc. | ADAGE CAPITAL PARTNERS GP LLC | 10% Owner | Buy | P | 12.90 | 20,000 | 258,000 | 5,914,366 | 5.9 M to 5.9 M (+0.34 %) |
| Aug 24 2015 | ADXS | Advaxis, Inc. | ADAGE CAPITAL PARTNERS GP LLC | 10% Owner | Buy | P | 13.87 | 5,000 | 69,350 | 5,894,366 | 5.9 M to 5.9 M (+0.08 %) |
| Aug 24 2015 | ADXS | Advaxis, Inc. | ADAGE CAPITAL PARTNERS GP LLC | 10% Owner | Buy | P | 14.21 | 75,000 | 1,065,750 | 5,889,366 | 5.8 M to 5.9 M (+1.29 %) |
| Aug 24 2015 | ADXS | Advaxis, Inc. | ADAGE CAPITAL PARTNERS GP LLC | 10% Owner | Buy | P | 14.17 | 12,000 | 170,040 | 5,814,366 | 5.8 M to 5.8 M (+0.21 %) |
| Aug 24 2015 | ADXS | Advaxis, Inc. | ADAGE CAPITAL PARTNERS GP LLC | 10% Owner | Buy | P | 14.31 | 13,600 | 194,616 | 5,802,366 | 5.8 M to 5.8 M (+0.23 %) |
| Aug 24 2015 | ADXS | Advaxis, Inc. | ADAGE CAPITAL PARTNERS GP LLC | 10% Owner | Buy | P | 14.32 | 45,582 | 652,734 | 5,788,766 | 5.7 M to 5.8 M (+0.79 %) |
| Aug 24 2015 | ADXS | Advaxis, Inc. | ADAGE CAPITAL PARTNERS GP LLC | 10% Owner | Buy | P | 14.28 | 103,818 | 1,482,521 | 5,743,184 | 5.6 M to 5.7 M (+1.84 %) |
| Aug 04 2015 | HTWR | HeartWare Internat ... | ADAGE CAPITAL PARTNERS GP LLC | 10% Owner | Sell | S | 90.03 | 9,200 | 828,276 | 1,722,969 | 1.7 M to 1.7 M (-0.53 %) |
| Aug 04 2015 | HTWR | HeartWare Internat ... | ADAGE CAPITAL PARTNERS GP LLC | 10% Owner | Sell | S | 90.08 | 10,000 | 900,800 | 1,732,169 | 1.7 M to 1.7 M (-0.57 %) |
| Aug 04 2015 | HTWR | HeartWare Internat ... | ADAGE CAPITAL PARTNERS GP LLC | 10% Owner | Sell | S | 90.12 | 800 | 72,096 | 1,742,169 | 1.7 M to 1.7 M (-0.05 %) |
| Aug 04 2015 | HTWR | HeartWare Internat ... | ADAGE CAPITAL PARTNERS GP LLC | 10% Owner | Sell | S | 90.02 | 5,000 | 450,100 | 1,742,969 | 1.7 M to 1.7 M (-0.29 %) |
| Aug 04 2015 | HTWR | HeartWare Internat ... | ADAGE CAPITAL PARTNERS GP LLC | 10% Owner | Sell | S | 91.38 | 10,000 | 913,800 | 1,747,969 | 1.8 M to 1.7 M (-0.57 %) |
| Aug 04 2015 | HTWR | HeartWare Internat ... | ADAGE CAPITAL PARTNERS GP LLC | 10% Owner | Sell | S | 92.00 | 75,000 | 6,900,000 | 1,757,969 | 1.8 M to 1.8 M (-4.09 %) |
| May 04 2015 | ADXS | Advaxis, Inc. | ADAGE CAPITAL PARTNERS GP LLC | 10% Owner | Buy | P | 19.00 | 500,000 | 9,500,000 | 5,639,366 | 5.1 M to 5.6 M (+9.73 %) |
| Apr 21 2015 | HTWR | HeartWare Internat ... | ADAGE CAPITAL PARTNERS GP LLC | 10% Owner | Sell | S | 80.36 | 19,447 | 1,562,761 | 1,832,969 | 1.9 M to 1.8 M (-1.05 %) |
| Apr 21 2015 | HTWR | HeartWare Internat ... | ADAGE CAPITAL PARTNERS GP LLC | 10% Owner | Sell | S | 80.53 | 700 | 56,371 | 1,852,416 | 1.9 M to 1.9 M (-0.04 %) |
| Apr 21 2015 | HTWR | HeartWare Internat ... | ADAGE CAPITAL PARTNERS GP LLC | 10% Owner | Sell | S | 80.61 | 1,800 | 145,098 | 1,853,116 | 1.9 M to 1.9 M (-0.10 %) |
| Apr 21 2015 | HTWR | HeartWare Internat ... | ADAGE CAPITAL PARTNERS GP LLC | 10% Owner | Sell | S | 80.54 | 2,400 | 193,296 | 1,854,916 | 1.9 M to 1.9 M (-0.13 %) |
| Apr 21 2015 | HTWR | HeartWare Internat ... | ADAGE CAPITAL PARTNERS GP LLC | 10% Owner | Sell | S | 80.05 | 74,134 | 5,934,427 | 1,875,316 | 1.9 M to 1.9 M (-3.80 %) |
| Apr 21 2015 | HTWR | HeartWare Internat ... | ADAGE CAPITAL PARTNERS GP LLC | 10% Owner | Sell | S | 80.90 | 7,000 | 566,300 | 1,931,450 | 1.9 M to 1.9 M (-0.36 %) |
| Apr 21 2015 | HTWR | HeartWare Internat ... | ADAGE CAPITAL PARTNERS GP LLC | 10% Owner | Sell | S | 80.50 | 5,000 | 402,500 | 1,938,450 | 1.9 M to 1.9 M (-0.26 %) |
| Apr 21 2015 | HTWR | HeartWare Internat ... | ADAGE CAPITAL PARTNERS GP LLC | 10% Owner | Sell | S | 80.83 | 7,141 | 577,207 | 1,943,450 | 2 M to 1.9 M (-0.37 %) |
| Apr 21 2015 | HTWR | HeartWare Internat ... | ADAGE CAPITAL PARTNERS GP LLC | 10% Owner | Sell | S | 80.84 | 5,000 | 404,200 | 1,950,591 | 2 M to 2 M (-0.26 %) |
| Apr 21 2015 | HTWR | HeartWare Internat ... | ADAGE CAPITAL PARTNERS GP LLC | 10% Owner | Sell | S | 80.99 | 5,000 | 404,950 | 1,955,591 | 2 M to 2 M (-0.26 %) |
| Apr 21 2015 | HTWR | HeartWare Internat ... | ADAGE CAPITAL PARTNERS GP LLC | 10% Owner | Sell | S | 82.01 | 3,900 | 319,839 | 1,960,591 | 2 M to 2 M (-0.20 %) |
| Apr 21 2015 | HTWR | HeartWare Internat ... | ADAGE CAPITAL PARTNERS GP LLC | 10% Owner | Sell | S | 81.18 | 9,300 | 754,974 | 1,964,491 | 2 M to 2 M (-0.47 %) |
| Apr 21 2015 | HTWR | HeartWare Internat ... | ADAGE CAPITAL PARTNERS GP LLC | 10% Owner | Sell | S | 83.49 | 13,245 | 1,105,825 | 1,973,791 | 2 M to 2 M (-0.67 %) |
| Apr 21 2015 | HTWR | HeartWare Internat ... | ADAGE CAPITAL PARTNERS GP LLC | 10% Owner | Sell | S | 81.00 | 6,700 | 542,700 | 1,987,036 | 2 M to 2 M (-0.34 %) |
| Apr 21 2015 | HTWR | HeartWare Internat ... | ADAGE CAPITAL PARTNERS GP LLC | 10% Owner | Sell | S | 80.95 | 12,500 | 1,011,875 | 1,993,736 | 2 M to 2 M (-0.62 %) |
| May 24 2013 | AVM | AMAG PHARMACEUTICA ... | ADAGE CAPITAL PARTNERS GP LLC | 10% Owner | Sell | D | 24.00 | 50,000 | 1,200,000 | 4,085,330 | 4.1 M to 4.1 M (-1.21 %) |
| Feb 04 2013 | BSBR | BOULDER BRANDS, IN ... | ADAGE CAPITAL PARTNERS GP LLC | 10% Owner | Sell | S | 13.50 | 1,600 | 21,600 | 5,939,492 | 5.9 M to 5.9 M (-0.03 %) |
| Feb 04 2013 | BSBR | BOULDER BRANDS, IN ... | ADAGE CAPITAL PARTNERS GP LLC | 10% Owner | Sell | S | 13.50 | 40,600 | 548,100 | 5,941,092 | 6 M to 5.9 M (-0.68 %) |
| Feb 04 2013 | BSBR | BOULDER BRANDS, IN ... | ADAGE CAPITAL PARTNERS GP LLC | 10% Owner | Sell | S | 13.52 | 67,800 | 916,656 | 5,981,692 | 6 M to 6 M (-1.12 %) |
| Feb 04 2013 | BSBR | BOULDER BRANDS, IN ... | ADAGE CAPITAL PARTNERS GP LLC | 10% Owner | Sell | S | 13.56 | 5,900 | 80,004 | 6,049,492 | 6.1 M to 6 M (-0.10 %) |
| Feb 04 2013 | BSBR | BOULDER BRANDS, IN ... | ADAGE CAPITAL PARTNERS GP LLC | 10% Owner | Sell | S | 13.52 | 185,700 | 2,510,664 | 6,055,392 | 6.2 M to 6.1 M (-2.98 %) |
| Jan 25 2013 | BSBR | BOULDER BRANDS, IN ... | ADAGE CAPITAL PARTNERS GP LLC | 10% Owner | Sell | S | 13.53 | 91,946 | 1,244,029 | 0 | 91.9 K to 0 (-100.00 %) |
| Jan 25 2013 | BSBR | BOULDER BRANDS, IN ... | ADAGE CAPITAL PARTNERS GP LLC | 10% Owner | Sell | S | 13.61 | 13,954 | 189,914 | 0 | 14 K to 0 (-100.00 %) |
| Jan 25 2013 | BSBR | BOULDER BRANDS, IN ... | ADAGE CAPITAL PARTNERS GP LLC | 10% Owner | Sell | S | 13.51 | 2,200 | 29,722 | 0 | 2.2 K to 0 (-100.00 %) |
| Jan 25 2013 | BSBR | BOULDER BRANDS, IN ... | ADAGE CAPITAL PARTNERS GP LLC | 10% Owner | Sell | S | 13.53 | 48,283 | 653,269 | 0 | 48.3 K to 0 (-100.00 %) |
| Jan 25 2013 | BSBR | BOULDER BRANDS, IN ... | ADAGE CAPITAL PARTNERS GP LLC | 10% Owner | Sell | S | 13.50 | 60,200 | 812,700 | 0 | 60.2 K to 0 (-100.00 %) |
| Jan 25 2013 | BSBR | BOULDER BRANDS, IN ... | ADAGE CAPITAL PARTNERS GP LLC | 10% Owner | Sell | S | 13.61 | 4,100 | 55,801 | 6,497,978 | 6.5 M to 6.5 M (-0.06 %) |
| Jan 02 2013 | BSBR | BOULDER BRANDS, IN ... | ADAGE CAPITAL PARTNERS GP LLC | 10% Owner | Sell | S | 13.00 | 700 | 9,100 | 6,502,078 | 6.5 M to 6.5 M (-0.01 %) |
| Jan 02 2013 | BSBR | BOULDER BRANDS, IN ... | ADAGE CAPITAL PARTNERS GP LLC | 10% Owner | Sell | S | 12.90 | 60,902 | 785,636 | 6,502,778 | 6.6 M to 6.5 M (-0.93 %) |
| Jan 02 2013 | BSBR | BOULDER BRANDS, IN ... | ADAGE CAPITAL PARTNERS GP LLC | 10% Owner | Sell | S | 12.86 | 56,238 | 723,221 | 6,563,680 | 6.6 M to 6.6 M (-0.85 %) |
| Jan 02 2013 | BSBR | BOULDER BRANDS, IN ... | ADAGE CAPITAL PARTNERS GP LLC | 10% Owner | Sell | S | 12.87 | 100,000 | 1,287,000 | 6,619,918 | 6.7 M to 6.6 M (-1.49 %) |
| Dec 21 2012 | BSBR | BOULDER BRANDS, IN ... | ADAGE CAPITAL PARTNERS GP LLC | 10% Owner | Sell | S | 13.33 | 1,704 | 22,714 | 6,719,918 | 6.7 M to 6.7 M (-0.03 %) |
| Dec 21 2012 | BSBR | BOULDER BRANDS, IN ... | ADAGE CAPITAL PARTNERS GP LLC | 10% Owner | Sell | S | 13.32 | 900 | 11,988 | 6,721,622 | 6.7 M to 6.7 M (-0.01 %) |
| Dec 21 2012 | BSBR | BOULDER BRANDS, IN ... | ADAGE CAPITAL PARTNERS GP LLC | 10% Owner | Sell | S | 13.46 | 127,900 | 1,721,534 | 6,722,522 | 6.9 M to 6.7 M (-1.87 %) |
| Dec 21 2012 | BSBR | BOULDER BRANDS, IN ... | ADAGE CAPITAL PARTNERS GP LLC | 10% Owner | Sell | S | 13.59 | 116,480 | 1,582,963 | 6,850,422 | 7 M to 6.9 M (-1.67 %) |
| Dec 21 2012 | BSBR | BOULDER BRANDS, IN ... | ADAGE CAPITAL PARTNERS GP LLC | 10% Owner | Sell | S | 13.58 | 3,400 | 46,172 | 6,966,902 | 7 M to 7 M (-0.05 %) |
| Dec 21 2012 | BSBR | BOULDER BRANDS, IN ... | ADAGE CAPITAL PARTNERS GP LLC | 10% Owner | Sell | S | 13.59 | 6,000 | 81,540 | 6,970,302 | 7 M to 7 M (-0.09 %) |
| Oct 09 2012 | BSBR | BOULDER BRANDS, IN ... | ADAGE CAPITAL PARTNERS GP LLC | 10% Owner | Sell | S | 12.51 | 295,000 | 3,688,975 | 6,976,302 | 7.3 M to 7 M (-4.06 %) |
| Oct 09 2012 | BSBR | BOULDER BRANDS, IN ... | ADAGE CAPITAL PARTNERS GP LLC | 10% Owner | Sell | S | 12.56 | 26,500 | 332,708 | 7,271,302 | 7.3 M to 7.3 M (-0.36 %) |
| Oct 09 2012 | BSBR | BOULDER BRANDS, IN ... | ADAGE CAPITAL PARTNERS GP LLC | 10% Owner | Sell | S | 12.55 | 10,000 | 125,500 | 7,297,802 | 7.3 M to 7.3 M (-0.14 %) |
| Oct 09 2012 | BSBR | BOULDER BRANDS, IN ... | ADAGE CAPITAL PARTNERS GP LLC | 10% Owner | Sell | S | 12.54 | 700 | 8,778 | 7,307,802 | 7.3 M to 7.3 M (-0.01 %) |
| Oct 09 2012 | BSBR | BOULDER BRANDS, IN ... | ADAGE CAPITAL PARTNERS GP LLC | 10% Owner | Sell | S | 12.75 | 15,300 | 195,090 | 7,308,502 | 7.3 M to 7.3 M (-0.21 %) |
| Oct 09 2012 | BSBR | BOULDER BRANDS, IN ... | ADAGE CAPITAL PARTNERS GP LLC | 10% Owner | Sell | S | 12.77 | 19,500 | 248,918 | 7,323,802 | 7.3 M to 7.3 M (-0.27 %) |
| Dec 20 2012 | PBYI | PUMA BIOTECHNOLOGY ... | ADAGE CAPITAL PARTNERS GP LLC | 10% Owner | Buy | P | 18.96 | 3,000 | 56,882 | 5,242,519 | 5.2 M to 5.2 M (+0.06 %) |
| Dec 20 2012 | PBYI | PUMA BIOTECHNOLOGY ... | ADAGE CAPITAL PARTNERS GP LLC | 10% Owner | Buy | P | 19.00 | 26,560 | 504,640 | 5,239,519 | 5.2 M to 5.2 M (+0.51 %) |
| Dec 14 2012 | PBYI | PUMA BIOTECHNOLOGY ... | ADAGE CAPITAL PARTNERS GP LLC | 10% Owner | Buy | P | 19.00 | 20,000 | 380,000 | 0 | -20,000 to 0 (-100.00 %) |
| Dec 14 2012 | PBYI | PUMA BIOTECHNOLOGY ... | ADAGE CAPITAL PARTNERS GP LLC | 10% Owner | Buy | P | 19.00 | 10,400 | 197,550 | 5,192,959 | 5.2 M to 5.2 M (+0.20 %) |
| Dec 11 2012 | PBYI | PUMA BIOTECHNOLOGY ... | ADAGE CAPITAL PARTNERS GP LLC | 10% Owner | Buy | P | 19.00 | 17,000 | 323,000 | 5,182,559 | 5.2 M to 5.2 M (+0.33 %) |
| Dec 11 2012 | PBYI | PUMA BIOTECHNOLOGY ... | ADAGE CAPITAL PARTNERS GP LLC | 10% Owner | Buy | P | 19.00 | 25,000 | 475,000 | 5,165,559 | 5.1 M to 5.2 M (+0.49 %) |
| Dec 11 2012 | PBYI | PUMA BIOTECHNOLOGY ... | ADAGE CAPITAL PARTNERS GP LLC | 10% Owner | Buy | P | 19.00 | 50,000 | 950,000 | 5,140,559 | 5.1 M to 5.1 M (+0.98 %) |
| Dec 11 2012 | PBYI | PUMA BIOTECHNOLOGY ... | ADAGE CAPITAL PARTNERS GP LLC | 10% Owner | Buy | P | 18.95 | 48,040 | 910,550 | 5,090,559 | 5 M to 5.1 M (+0.95 %) |
| Oct 22 2012 | PBYI | PUMA BIOTECHNOLOGY ... | ADAGE CAPITAL PARTNERS GP LLC | 10% Owner | Buy | P | 16.00 | 610,000 | 9,760,000 | 5,042,519 | 4.4 M to 5 M (+13.76 %) |
| Jul 27 2012 | PBYI | PUMA BIOTECHNOLOGY ... | ADAGE CAPITAL PARTNERS GP LLC | 10% Owner | Buy | P | 12.50 | 450,000 | 5,625,000 | 4,432,519 | 4 M to 4.4 M (+11.30 %) |
| Jul 27 2012 | PBYI | PUMA BIOTECHNOLOGY ... | ADAGE CAPITAL PARTNERS GP LLC | 10% Owner | Buy | P | 12.00 | 154,000 | 1,848,000 | 3,982,519 | 3.8 M to 4 M (+4.02 %) |
| Jul 18 2012 | PBYI | PUMA BIOTECHNOLOGY ... | ADAGE CAPITAL PARTNERS GP LLC | 10% Owner | Buy | P | 11.21 | 153,000 | 1,715,130 | 3,967,119 | 3.8 M to 4 M (+4.01 %) |
| Jul 03 2012 | PBYI | PUMA BIOTECHNOLOGY ... | ADAGE CAPITAL PARTNERS GP LLC | 10% Owner | Buy | P | 11.08 | 2,424 | 26,858 | 3,814,119 | 3.8 M to 3.8 M (+0.06 %) |
| Jul 03 2012 | PBYI | PUMA BIOTECHNOLOGY ... | ADAGE CAPITAL PARTNERS GP LLC | 10% Owner | Buy | P | 11.14 | 27,000 | 300,780 | 3,811,695 | 3.8 M to 3.8 M (+0.71 %) |
| Jul 03 2012 | PBYI | PUMA BIOTECHNOLOGY ... | ADAGE CAPITAL PARTNERS GP LLC | 10% Owner | Buy | P | 11.03 | 149,000 | 1,643,470 | 3,784,195 | 3.6 M to 3.8 M (+4.10 %) |
| May 03 2012 | PBYI | PUMA BIOTECHNOLOGY ... | ADAGE CAPITAL PARTNERS GP LLC | 10% Owner | Buy | P | 13.25 | 8,500 | 112,625 | 3,635,695 | 3.6 M to 3.6 M (+0.23 %) |